|
|
||||||||
The Journal of Immunology, Vol 142, Issue 1 126-133, Copyright © 1989 by American Association of Immunologists
ARTICLES |
TA Bird and J Saklatvala
Strangeways Research Laboratory, Cambridge, United Kingdom.
The effect of the human rIL-1 alpha and rTNF-alpha on the binding of 125I-labeled epidermal growth factor ([125I]EGF) to its receptor (EGF- R) has been studied in human gingival fibroblasts (HuGi). Incubation of these cells with recombinant cytokines at 37 degrees C caused a rapid, dose-dependent decrease in their ability to subsequently bind subsaturating levels of [125I]EGF at 4 degrees C. Inhibition was evident at 5 min after addition of cytokines, reached a maximal level (60-70% reduction) after 15 to 30 min, and declined thereafter. Normal EGF binding was attained by 2 h. Half-maximal inhibition of EGF binding occurred at 10 pM IL-1 and 50 pM TNF. The two cytokines were not additive in their effect. Competition experiments at 4 degrees C showed that the cytokines did not interact directly with EGF-R; Scatchard analysis of binding of [125I]EGF to HuGi after treatment with IL-1 and TNF revealed an increase in EGF-R Kd from 0.75 nM to 2.9 nM with no change in receptor number. The effect of IL-1 and TNF on EGF-R was compared with that of the tumor-promotor PMA which is known to "transmodulate" EGF-R affinity by activating protein kinase C which then phosphorylates EGF-R. PMA caused a greater inhibition of EGF binding to HuGi (80 to 85% inhibition; ED50 = 500 pM), and recovery of binding was much slower. Importantly, in HuGi made deficient in protein kinase C by prolonged incubation with PMA, addition of fresh PMA no longer affected EGF binding, while the response to IL-1 and TNF was intact. Cytokine- but not PMA-mediated EGF-R transmodulation was partially reversed by treatment of the cells with millimolar concentrations of the kinase inhibitor amiloride. HuGi were incubated with H3 32PO4, stimulated with PMA or cytokines, and EGF-R were immunoprecipitated; IL-1 and TNF, like PMA, caused a 2- to 5-fold increase in receptor phosphorylation. We conclude that occupation of IL- 1 and TNF-R activates a protein kinase, distinct from kinase C, for which EGF-R is a substrate.
This article has been cited by other articles:
![]() |
S. Murthy, S. N. Mathur, and F. J. Field Tumor Necrosis Factor-alpha and Interleukin-1beta Inhibit Apolipoprotein B Secretion in CaCo-2 Cells via the Epidermal Growth Factor Receptor Signaling Pathway J. Biol. Chem., March 24, 2000; 275(13): 9222 - 9229. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Lazarovici, M. Oshima, D. Shavit, M. Shibutani, H. Jiang, M. Monshipouri, D. Fink, V. Movsesyan, and G. Guroff Down-regulation of Epidermal Growth Factor Receptors by Nerve Growth Factor in PC12 Cells Is p140trk-, Ras-, and Src-dependent J. Biol. Chem., April 25, 1997; 272(17): 11026 - 11034. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. N. Denisenko, B. O'Neill, J. Ostrowski, I. Van Seuningen, and K. Bomsztyk Zik1, a Transcriptional Repressor That Interacts with the Heterogeneous Nuclear Ribonucleoprotein Particle K Protein J. Biol. Chem., November 1, 1996; 271(44): 27701 - 27706. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Mathias, A Younes, C. Kan, I Orlow, C Joseph, and R. Kolesnick Activation of the sphingomyelin signaling pathway in intact EL4 cells and in a cell-free system by IL-1 beta Science, January 22, 1993; 259(5094): 519 - 522. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |